Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx

Journal of the National Cancer Institute

Volumn 88, Issue 22, 1996, Pages 1676-1682

  Scholnick, Steven B ^a   Haughey, Bruce H ^a   Sunwoo, John B ^a   El Mofty, Samir K ^a   Baty, Jack D ^a   Piccirillo, Jay F ^a   Zequeira, Maria R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GENETICS; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME 8P; CHROMOSOME LOSS; DNA DETERMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

ALLELES; CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; GLOTTIS; HETEROZYGOTE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 0029849630     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.22.1676     Document Type: Article

References (30)

1. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6.
2. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment [see comment citation in Medline]. J Clin Oncol 1993;11:1466-77.
3. Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, et al. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 1995;87:1470-6.
4. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas [see comment citation in Medline]. J Natl Cancer Inst 1993;85:377-84.
5. Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T. et al. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 1993;53:1172-4.
6. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, et al. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 1994;9: 3071-6.
7. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer 1994;10:151-9.
8. Knowles MA, Shaw ME, Proctor AJ. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 1993;8:1357-64.
9. Emi M, Fujiwara Y, Ohata H, Tsuda H, Hirohashi S, Koike M, et al. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer 1993;7: 152-7.
10. Ichikawa T, Nihei N, Suzuki H, Oshimura M, Emi M, Nakamura Y, et al. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res 1994;54:2299-302.
11. Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y, et al. Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3. Genes Chromosomes Cancer 1995;13:168-74.
12. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994;54:1152-5.
13. EI-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res 1995;55: 2656-9.
14. Li X, Lee NK, Ye YW, Waber PG, Schweitzer C, Cheng QC, et al. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 1994;86:1524-9.
15. Sunwoo JB, Holt MS, Radford DM, Scholnick SB. Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer. Genes Chromosomes Cancer 1996;16:164-9.
16. Scholnick SB, Sun PC, Shaw ME, Haughey BH, El-Mofty SK. Frequent loss of heterozygosity for Rb, TP53, and chromosome arm 3p, but not NME1 in squamous cell carcinomas of the supraglottic larynx. Cancer 1994;73:2472-80.
17. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974;27:387-404.
18. Beahrs OH, Henson DE, Mutter RV, Kennedy BJ, editors. A manual for staging cancer. Philadelphia: Lippincott, 1992.
19. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-81.
20. Cox DR. Regression models and life tables. J R Stat Soc - B 1972;34:187-220.
21. Snow GB, Annyas AA, van Slooten EA, Bartelink H, Hart AA. Prognostic factors of neck node metastasis. Clin Otolaryngol 1982;7:185-92.
22. Stell PM. Prognosis in laryngeal carcinoma: tumour factors. Clin Otolaryngol 1990;15:69-81.
23. Levendag PC, Veeze-Kuijpers B, Knegt PP, De Boer MF, Eijkenboom WM, Reichgelt BA, et al. Cancer of the supraglottic larynx with neck node metastasis treated by radiation therapy only. The revised 1987 UICC classification system as prognostic indicator. Acta Oncol 1990;29:603-9.
24. Zatlerstrom UK, Wennerberg J, Ewers SB, Willen R, Attewell R. Prognostic factors in head and neck cancer: histologic grading, DNA ploidy, and nodal status. Head Neck 1991;13:477-87.
25. Maddox WA. Hayes Martin lecture. Vicissitudes of head and neck cancer. Am J Surg 1984;148:428-32.
26. Goldsmith MM, Belchis DA, Cresson DH, Merritt WD 3d, Askin FB. The importance of the eosinophil in head and neck cancer. Otolaryngol Head Neck Surg 1992;106:27-33.
27. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer 1996;77: 834-42.
28. Feinstein AR, Schimpff CR, Andrews JF Jr, Wells CK. Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment. J Chronic Dis 1977;30:277-305.
29. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR. New clinical severity staging system for cancer of the larynx. Five-year survival rates. Ann Otol Rhinol Laryngol 1994; 103:83-92.
30. Stell PM. Prognosis in laryngeal carcinoma: host factors. Clin Otolaryngol 1990;15:111-9.